Stéphane Champiat
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 97
- Cancer Immunotherapy and Biomarkers 78
- CAR-T cell therapy research 27
- Lung Cancer Research Studies 13
- Colorectal Cancer Treatments and Studies 8
- Immunology 31
- Immunotherapy and Immune Responses 15
- Immune Cell Function and Interaction 10
- Co-authors
- Aurélien Marabelle (76 shared papers)Jean‐Charles Soria (31 shared papers)Christophe Massard (36 shared papers)Charles Ferté (7 shared papers)Samy Ammari (23 shared papers)Antoine Hollebecque (29 shared papers)Olivier Lambotte (25 shared papers)Caroline Robert (20 shared papers)
- Journals
- Annals of Oncology (20 papers)European Journal of Cancer (18 papers)Journal of Clinical Oncology (15 papers)Clinical Cancer Research (6 papers)Cancer Research (4 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Stéphane Champiat
124 papers receiving 7.3k citations
Stéphane Champiat's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 4.7k
- Immunology 1.7k
- Pulmonary and Respiratory Medicine 1.3k
- Radiology, Nuclear Medicine and Imaging 820
- Hepatology 259
Countries citing papers authored by Stéphane Champiat
This map shows the geographic impact of Stéphane Champiat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Champiat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Champiat more than expected).
Fields of papers citing papers by Stéphane Champiat
This network shows the impact of papers produced by Stéphane Champiat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Champiat. The network helps show where Stéphane Champiat may publish in the future.
Co-authors
The 25 scholars most cited alongside Stéphane Champiat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1 Hit paper breakdown → | 2016 | 875 |
| 2 | A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study Hit paper breakdown → | 2018 | 855 |
| 3 | Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination Hit paper breakdown → | 2016 | 826 |
| 4 | Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab Hit paper breakdown → | 2015 | 513 |
| 5 | Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors Hit paper breakdown → | 2018 | 387 |
| 6 | Novel patterns of response under immunotherapy Hit paper breakdown → | 2019 | 361 |
| 7 | Intratumoural administration and tumour tissue targeting of cancer immunotherapies Hit paper breakdown → | 2021 | 359 |
| 8 | 2019 | 273 | |
| 9 | 2018 | 271 | |
| 10 | 2020 | 194 | |
| 11 | 2014 | 156 | |
| 12 | 2017 | 149 | |
| 13 | 2017 | 126 | |
| 14 | 2019 | 119 | |
| 15 | 2018 | 108 | |
| 16 | 2017 | 108 | |
| 17 | 2018 | 94 | |
| 18 | 2018 | 92 | |
| 19 | 2020 | 91 | |
| 20 | 2023 | 87 |
About Stéphane Champiat
Stéphane Champiat is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 132 papers that have together received 7.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (78 papers), CAR-T cell therapy research (27 papers), Immunotherapy and Immune Responses (15 papers), Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (13 papers), Immune Cell Function and Interaction (10 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). The work is most often cited by research in Oncology (4.7k citations), Immunology (1.7k citations), Pulmonary and Respiratory Medicine (1.3k citations), Radiology, Nuclear Medicine and Imaging (820 citations) and Hepatology (259 citations). Stéphane Champiat has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Aurélien Marabelle, Jean‐Charles Soria, Christophe Massard, Charles Ferté, Samy Ammari, Antoine Hollebecque, Olivier Lambotte, Caroline Robert, Laurent Dercle and Alexander M.M. Eggermont. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.